Literature DB >> 3768249

Protein binding of chloroquine enantiomers and desethylchloroquine.

D Ofori-Adjei, O Ericsson, B Lindström, F Sjöqvist.   

Abstract

The protein binding of racemic chloroquine, its enantiomers and desethylchloroquine to plasma, purified human albumin, and alpha 1-acid glycoprotein (alpha 1-AGP) was determined by equilibrium dialysis. The binding was not concentration dependent. (+)-Chloroquine bound more to plasma (66.6 +/- 1.9%) and albumin (45.9 +/- 0.8%) than (-)-chloroquine (48.5 +/- 2.4% and 35.3 +/- 0.6%, respectively). These differences were statistically significant. (-)-Chloroquine bound more to alpha 1-AGP (47.5 +/- 0.7%) than (+)-chloroquine (34.5 +/- 0.5%). The binding of desethylchloroquine to alpha 1-AGP is higher than to albumin (38.9 +/- 0.9% and 21.1 +/- 0.4%, respectively.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768249      PMCID: PMC1401130          DOI: 10.1111/j.1365-2125.1986.tb02900.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  In vitro activity of chloroquine, the two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum.

Authors:  S Fu; A Björkman; B Wåhlin; D Ofori-Adjei; O Ericsson; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

2.  Blood levels and in vitro activity of desethylchloroquine against Plasmodium falciparum.

Authors:  F Verdier; J Le Bras; F Clavier; I Hatin
Journal:  Lancet       Date:  1984-05-26       Impact factor: 79.321

3.  Determination of chloroquine and its desethyl metabolite in plasma, red blood cells and urine by liquid chromatography.

Authors:  G Alván; L Ekman; B Lindström
Journal:  J Chromatogr       Date:  1982-04-16

4.  Characterization of chloroquine plasma protein binding in man.

Authors:  O Walker; D J Birkett; G Alván; L L Gustafsson; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

5.  Antimalarial activity of the optical isomers of chloroquine diphosphate.

Authors:  A Haberkorn; H P Kraft; G Blaschke
Journal:  Tropenmed Parasitol       Date:  1979-09

6.  In vitro assessment of the antimalarial activity of chloroquine and its major metabolites.

Authors:  A F Aderounmu
Journal:  Ann Trop Med Parasitol       Date:  1984-12
  6 in total
  17 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  Stereoselective plasma protein binding of ibuprofen enantiomers.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.

Authors:  J Ducharme; R Farinotti
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

Review 4.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

5.  Stereoselective pharmacokinetic properties of chloroquine and de-ethyl-chloroquine in humans.

Authors:  P Augustijns; N Verbeke
Journal:  Clin Pharmacokinet       Date:  1993-03       Impact factor: 6.447

Review 6.  Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs.

Authors:  Dion R Brocks; Reza Mehvar
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Plasma protein binding of the enantiomers of hydroxychloroquine and metabolites.

Authors:  A J McLachlan; D J Cutler; S E Tett
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis.

Authors:  P Augustijns; P Geusens; N Verbeke
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 9.  Clinical pharmacokinetics of slow-acting antirheumatic drugs.

Authors:  S E Tett
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

Review 10.  HPLC methods for choloroquine determination in biological samples and pharmaceutical products.

Authors:  Yugo Araújo Martins; Talita Mota Gonçalves; Renata F V Lopez
Journal:  Daru       Date:  2021-03-19       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.